Affiliation: University of Rochester
- Effect of Gender on the Risk of Neurologic Events and Subsequent Outcomes in Patients With Left Ventricular Assist DevicesSaadia Sherazi
Cardiology Division, University of Rochester School of Medicine and Dentistry, Rochester, New York Electronic address
Am J Cardiol 119:297-301. 2017..001, interaction p = 0.854). In conclusion, among patients with LVAD, women are at greater risk of neurologic event compared to men. Both women and men after LVAD have similar high risk of all-cause mortality after neurologic events...
- Predictors of mortality in patients hospitalized for congestive heart failure with left ventricular ejection fraction ≥ 40Saadia Sherazi
Department of Cardiology at University of Rochester Medical Center, Rochester, New York, United States
Cardiol J 22:382-90. 2015..There are limited data regarding the predictors of mortality in patients with acute congestive heart failure (CHF) and left ventricular ejection fraction (LVEF) ≥ 40%...
- Comparison of low versus high (>40 mm Hg) pulse pressure to predict the benefit of cardiac resynchronization therapy for heart failure (from the Multicenter Automatic Defibrillator Implantation Trial-Cardiac Resynchronization Therapy Trial)Saadia Sherazi
Cardiovascular Division, University of Rochester Medical Center, Rochester, New York Electronic address
Am J Cardiol 114:1053-8. 2014..001), compared with patients with low PP. In conclusion, high baseline PP is an independent predictor of echocardiographic response to CRT-D, and high PP after device implantation is associated with improved subsequent clinical outcome...
- Physicians' preferences and attitudes about end-of-life care in patients with an implantable cardioverter-defibrillatorSaadia Sherazi
Department of Community and Preventive Medicine, University of Rochester Medical Center, PO Box 644, 601 Elmwood Ave, Rochester, NY 14642, USA
Mayo Clin Proc 83:1139-41. 2008..With increased knowledge about managing the withdrawal of this potentially life-prolonging therapy, physicians are likely to become more skilled at caring for dying patients with an ICD...
- End-of-life care in patients with implantable cardioverter defibrillators: a MADIT-II substudySaadia Sherazi
Heart Research Follow Up Program, University of Rochester Medical Center, Rochester, New York
Pacing Clin Electrophysiol 36:1273-9. 2013..This study was designed to describe the patterns of end-of-life management in patients with ICDs...
- Metabolic syndrome is associated with different clinical outcome after cardiac resynchronization therapy in patients with ischemic and non-ischemic cardiomyopathyBarbara Szepietowska
University of Rochester Medical Center, Rochester, New York, United States
Cardiol J 23:344-51. 2016....
- Physicians' knowledge and attitudes regarding implantable cardioverter-defibrillatorsSaadia Sherazi
Department of Medicine, Unity Health System, Rochester, NY 14626, USA
Cardiol J 17:267-73. 2010..Information is limited regarding the knowledge and attitudes of physicians typically involved in the referral of patients for implantable cardioverter-defibrillator (ICD) implantation...
- Predictors and clinical relevance of ventricular tachyarrhythmias in ambulatory patients with a continuous flow left ventricular assist deviceAyhan Yoruk
University of Rochester Medical Center, Rochester, New York
Heart Rhythm 13:1052-6. 2016..Patients with a left ventricular assist device (LVAD) are at high risk for ventricular tachyarrhythmias (VTAs)...
- Corrected QT interval as a predictor of mortality in elderly patients with syncopeAshim Aggarwal
Department of Internal Medicine, Unity Health System, 1555 Long Pond Road, Rochester, NY 14616, USA
Cardiol J 18:395-400. 2011..However, its association with all cause or cardiac mortality in the general population remains unclear. We evaluated the relationship between prolonged QTc and total mortality among patients with syncope...
- Effect of obesity on the effectiveness of cardiac resynchronization to reduce the risk of first and recurrent ventricular tachyarrhythmia eventsBarbara Szepietowska
Heart Research Follow Up Program, Cardiology Division, University of Rochester Medical Center, 265 Crittenden Blvd, PO Box 653, Rochester, NY, 14642, USA
Cardiovasc Diabetol 15:93. 2016....
- Effect of biventricular pacing during a ventricular sensed eventMehmet Kemal Aktas
Cardiology Department, University of Rochester Medical Center, Rochester, New York, USA
Am J Cardiol 103:1741-5. 2009....
- Left ventricular ejection fraction normalization in cardiac resynchronization therapy and risk of ventricular arrhythmias and clinical outcomes: results from the Multicenter Automatic Defibrillator Implantation Trial With Cardiac Resynchronization TherapyMartin H Ruwald
From the Heart Research Follow up Program, Division of Cardiology, University of Rochester Medical Center, Rochester, NY M H R, V K, A C R, S S, S M, A J M, W Z Department of Cardiology, Gentofte Hospital, Hellerup, Denmark M H R, A C R, C J Cardiovascular Division, Brigham and Women s Hospital, Harvard Medical School, Boston, MA S D S and Division of Cardiology, Department of Medicine, University of California, San Francisco E F
Circulation 130:2278-86. 2014..Appropriate guideline criteria for use of implantable cardioverter-defibrillators (ICDs) do not take into account potential recovery of left ventricular ejection fraction (LVEF) in patients treated with CRT-defibrillator...
- Diastolic heart failure: predictors of mortalitySaadia Sherazi
Department of Medicine, Unity Health System, Rochester, NY, USA
Cardiol J 18:222-32. 2011..5 cm/s are predictors of adverse outcomes in diastolic HF patients...
- Moxifloxacin-induced torsades de pointesSaadia Sherazi
Unity Health System, Department of Medicine, University of Rochester Medical Center, Rochester, NY 14626, USA
Cardiol J 15:71-3. 2008..Although it is difficult to predict which patients are at risk from TdP, careful assessment of the risk/benefit ratio is important before prescribing drugs known to cause QT prolongation...